* Prestige Consumer Healthcare Inc PBH.N PBH is expected to
show a fall in quarterly revenue when it reports results on May
6.
* The Tarrytown, New York-based company is expected to report a
8.5% decrease in revenue to $229.905 million from $251.24
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Prestige Consumer
Healthcare Inc is for earnings of 78 cents per share. For the
same quarter last year, the company reported earnings of 82
cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Prestige
Consumer Healthcare Inc is $47.5, about 6.7% above its last
closing price of $44.33.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 0.77 0.77 0.81 Beat 5.6
Sep. 30 2020 0.72 0.72 0.78 Beat 8.8
Jun. 30 2020 0.70 0.70 0.86 Beat 22.9
Mar. 31 2020 0.75 0.74 0.82 Beat 11.2
Dec. 0.76 0.76 0.81 Beat 7.3
31 2019
Sep. 30 2019 0.65 0.66 0.68 Beat 3.7
Jun. 30 2019 0.64 0.64 0.65 Beat 2.1
Mar. 31 2019 0.70 0.70 0.72 Beat 2.3
This summary was machine generated May 4 at 15:54 GMT. All
figures in US dollars unless otherwise stated